Check the price of trametinib plus hydroxychloroquine, and know the budget for the combination drug in advance!

Trametinib/Megenin (Trametinib) is a highly selective MEK inhibitor, mainly used to treat malignant melanoma, thyroid cancer, and non-small cell lung cancer related to BRAF V600 mutations. Studies have shown that trametinib alone or in combination with the BRAF inhibitor dabrafenib can effectively delay disease progression and improve patient survival rates. However, in recent years, scientists have begun to study the potential of trametinib in combination with Hydroxychloroquine, especially in overcoming drug resistance and improving treatment efficacy.

Hydroxychloroquine is a traditional anti-malarial and anti-rheumatic immune drug. In recent years, it has attracted attention from cancer research due to its role in autophagy inhibition. Research shows that the autophagy mechanism plays an important role in tumor cell survival. MEK inhibitors, while inhibiting the MAPK signaling pathway, may activate autophagy in tumor cells, allowing them to adapt to stress and evade immune clearance. Hydroxychloroquine can inhibit the autophagy process, and its combined use with trametinib may enhance its anti-tumor activity, reduce drug resistance, and improve therapeutic efficacy.

In terms of medication costs, the original drug of trametinib has been launched in China and has been included in the medical insurance catalog, but the scope of medical insurance reimbursement only applies to specific indications. In the domestic market, the common specifications of trametinib are 2mg×30 tablets and 0.5mg×30 tablets, with the price per box being approximately RMB 10,000. In addition, some countries, such as Laos and India, have launched generic versions of trametinib. The ingredients are basically the same as the original drug, but the price is lower, ranging from about 1,000 to 3,000 yuan per box.

The price of hydroxychloroquine is relatively low and it is a more economical auxiliary drug. In the domestic market, the price of each bottle of hydroxychloroquine (100 tablets) is about 100-200 yuan, while in countries such as India and Bangladesh, the price of imitation hydroxychloroquine is even lower, and the price of each bottle may be as low as tens of yuan. Therefore, the additional financial burden of hydroxychloroquine is smaller for patients requiring long-term combination therapy, while the major cost remains focused on trametinib.

Reference materials:https://go.drugbank.com/drugs/DB08911